Read General/Non-Preferred Drug Prior Authorization Form text version

Prior Authorization Form Long Acting Narcotics

***All PA forms may be found by accessing https://tnm.providerportal.sxc.com/rxclaim/TNM/PAs.htm.***

If the following information is not complete, correct, or legible the PA process can be delayed. Use one form per member please.

Member Information

Last Name ID Number First Name Date of Birth

-

-

Prescriber Information

Last Name Office Address City NPI# Phone State DEA# Zip First Name

-

-

Fax

-

-

Requested Long-Acting Narcotic

**PREFERRED** Kadian® morphine sulfate SA Opana ER® oxymorphone SR Avinza® Butrans® Dolophine® Duragesic® Strength___________ EmbedaTM ExalgoTM fentanyl patch methadone Non-Preferred Methadose® morphine sulfate SR 24 hour Nucynta® ER Oramorph® SR Quantity Requested_____________ oxycodone SR Oxycontin®

Directions _______________________________________________ Yes No

Request to Backdate PA? TOTAL DAILY DOSE:

If Yes, Requested PA Start Date____________________

________________________

*** If requesting a total daily dose exceeding the threshold listed in the tables below, complete Questions 1-11 under Clinical Criteria Documentation. Otherwise, complete Questions 1-7, then skip to the Authorized Prescriber Signature section at the bottom of the form.

Drug

Avinza® Duragesic® / fentanyl patch EmbedaTM Kadian®/morphine sulfate SR 24 hr methadone /Methadose®

Daily Dosage Threshold

180 mg/day 75 mcg/hr: 10 patches per month - OR100 mcg/hr: 10 patches per month 200 mg/day morphine component 200 mg/day 40 mg/day

Drug

morphine sulfate SA MS Contin® Nucynta® ER Opana® ER/ oxymorphone SR Oramorph® SR oxycodone SR Oxycontin®

Daily Dosage Threshold

200 mg/day 200 mg/day 500 mg/day 80 mg/day 200 mg/day 160 mg/day 160 mg/day

Clinical Criteria Documentation 1. Diagnosis (please check all that apply): Cancer pain Chronic back pain 2. Sickle cell disease Fibromyalgia

****Do not include documentation that is not requested on this form**** HIV/AIDS Hospice patient Other____________________________________ (specify and list ICD-9)

Initial date of diagnosis: _________________________ Provide details for patient's history of opioid use:

Date narcotics initiated for diagnosis: ___________________________

Drug 1:_________________________ Strength: _______________ SIG: ______________________ Dates: _________________ Reason for discontinuation of the drug: __________________________________________________________________________ Drug 2:_________________________ Strength: _______________ SIG: ______________________ Dates: _________________ Reason for discontinuation of the drug: __________________________________________________________________________ Drug 3:_________________________ Strength: _______________ SIG: ______________________ Dates: _________________ Reason for discontinuation of the drug: __________________________________________________________________________

Page 1 of 2

(continued on next page)

Revised 2/04/12

TennCare Prior Authorization Form: Long-Acting Narcotics ­ Page 2 ­

Patient Name:_____________________________________ 3. 4. 5. Does the patient have inability to swallow or absorb PO medications? Will this request be utilized for a dose titration? Yes No Yes No Yes No DOB_______________

Has the patient been on another long acting-acting narcotic within the last 30 days? If yes, has this medication been discontinued? Yes

No (please provide reason) _________________________________

___________________________________________________________________________________________________________ ___________________________________________________________________________________________________________ 6. Does this patient exhibit any of the following characteristics or behaviors? History of addiction to the requested drug Frequent reports of lost or stolen tablets History of parenteral substance abuse Yes (check all that apply) No

Frequent requests for early refills

Frequent requests for odd quantities

Requests for short term or PRN use of long-acting narcotics Evidence of diversion

Please explain any of the above check boxes: ______________________________________________________________________ ___________________________________________________________________________________________________________ 7. 8. 9. Document most recent date the provider checked the Tennessee Controlled Substance Database for this patient: _______________ Is the patient currently a resident in a long term care facility? Yes No If Yes, name of facility: _______________________________________________________________________________________ For Butrans requests only: What is the proposed tapering schedule for other opioid analgesics prior to initiation of Butrans? _________________________________________________________________________________________ __________________________________________________________________________________________________________ ***Requests for Total Daily Doses below the threshold in Table 2 may now skip to the Prescriber Signature section at the bottom of this page. All other requests must complete Questions 10-13. Narcotic Monitoring Information 10. Has a written medical treatment plan with stated objectives consistent with Board of Medical Examiner's rule 0880-2-.14 Yes No (website: http://www.tn.gov/sos/rules ) been established? 11. Has a Patient Controlled Substance Agreement been initiated for this patient? If yes, will this agreement be re-evaluated every 6 months? Yes No Yes No

12. Have you performed any of the following activities for this patient? Random urine screen Date______________ Pill counts Date______________ Pharmacy checks Date______________ Re-evaluated for pain relief and improved physical and psychosocial function 13. Has a specialist consultation been performed or scheduled for this patient? Neurology Board Certified Pain Management Rheumatology

Date______________ No

Yes (please specify) Oncology

Other________________________________________________________________

Please note any other information pertinent to this PA request: ____________________________________________________________ _______________________________________________________________________________________________________________ Prescriber Signature (REQUIRED):________________________________________________________Date: ____________________

(By signature, the physician confirms the above information is accurate and verifiable by patient records.)

Fax This Form to: 866-434-5523

Mail requests to: SXC Health Solutions PA Department, P.O. Box 3214, Lisle IL 60532-8214

Telephone 866-434-5524

SXC Health Solutions, Inc. will provide a response within 24 hours upon receipt.

This facsimile transmission contains legally privileged and confidential information intended for the parties identified below. If you have received this transmission in error, please immediately notify us by telephone and return the original message to P.O. Box 3214; Lisle, IL 60532-8214. Distribution, reproduction or any other use of this transmission by any party other than the intended recipient is strictly prohibited.

Page 2 of 2

Revised 2/04/12

Information

General/Non-Preferred Drug Prior Authorization Form

2 pages

Report File (DMCA)

Our content is added by our users. We aim to remove reported files within 1 working day. Please use this link to notify us:

Report this file as copyright or inappropriate

277385


You might also be interested in

BETA
Purdue - Medicine, Florida Board of
Criteria for Use of Oxycodone CR (OxyContin)